Genetic screening from peripheral blood shows a high sensitivity (95%-100%) for JAK2 (Janus kinase 2) mutations involving either exon 14 or 12, which helps distinguish PV from secondary polycythemia [11]. Here, JAK2 is linked to polycythemia.